MYDA Advisors’s Context Therapeutics CNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding CNTX
MYDA Advisors's CNTX Position: Q3 2026 in Review
MYDA Advisors opened a new position in Context Therapeutics (CNTX) in Q3 2026: 250,000 shares worth $75.1K. The stake represents 0.01% of the portfolio and ranks #197 among its holdings.
87 funds tracked by Wall St. Rank hold CNTX as of Q3 2026.
- MYDA Advisors held 250,000 shares of Context Therapeutics worth $75.1K as of Q3 2026.
- Context Therapeutics was a new MYDA Advisors position in Q3 2026.
- Context Therapeutics made up 0.01% of MYDA Advisors's portfolio in Q3 2026, its #197 holding.
- 87 funds tracked by Wall St. Rank held Context Therapeutics as of Q3 2026.
Based on MYDA Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.